Sentences with phrase «includes outcome data»

Loss to follow - up was a particular problem in studies where women were recruited in the antenatal period and, as we have described above, we have not included any outcome data from studies that were otherwise eligible for inclusion in the review because of high levels of attrition for all outcomes.

Not exact matches

It incorporated through Victoria University in New Zealand, obtained a no - action letter from the CFTC, and struck deals with 83 research institutions, including the U.S. Federal Reserve, to provide data about how well prediction markets forecast correct outcomes.

Hot topics, as usual, include the use of data in health care, AI, digital health apps, and how to turn all of those things into products and services that actually produce real outcomes.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

The report uses internal government data to provide an overview of economic and social outcomes of immigrants from all sources, including economic - class, family - class and refugee streams.

21:09 — Andy explains how Wealthfront uses data from various sources, including connected accounts, to determine the best plan for each user and to provide better financial outcomes than a traditional planner could conceive.

The Abacus study also asked those who voted in the 2015 Canadian General Election to rank a ballot that included the main political parties and generated data for 11 regions to estimate, with increased precision, the outcome of the Canadian election had it been run under different electoral systems.

The Technical Report, which provides a comprehensive assessment of ecological outcomes to environmental flows in the Edward - Wakool Selected Area in 2014 - 15, including details on data analysis techniques and statistical outputs, is expected to be published by late February 2016.

«We hope this project allows us to generate data to show that implementing regenerative agriculture practices results in improved outcomes — including economic resiliency and long - term benefits for farmers,» said Carla Vernón, president of the operating unit at Annie's, also owned by parent company General Mills.

Her work in systematic reviews has consistently addressed tough topics and has included documenting harms of episiotomy, the limitations of data about outcomes of fetal surgery, inconsistencies in results of programs designed to reduce use of cesarean, marginal effectiveness of medications for overactive bladder, and the burden on cervical cancer prevention programs introduced by liquid cytology collection for pap testing.

We also calculated outcome rates before reclassification to determine the effect of misclassification in standard vital statistics data, including prior U.S. studies on place of birth.

Of the 31 new studies included in this update, 21 provided data for one or more of the primary outcomes.

Incorporating the vast majority of comparative birth studies to date in a contemporary appraisal of elective cesarean delivery in healthy women is flawed, primarily because their data includes outcomes from emergency surgeries and elective surgeries in women (and babies) with pre-existing medical conditions.

In addition, much of the data compiled on vaginal delivery looks at «positive outcomes» alone (i.e. a planned vaginal delivery that ends up as a vaginal delivery) rather than «all planned vaginal delivery outcomes» (including those that result in emergency cesareans) and their subsequent mortalities or morbidities.

For the purposes of this economic evaluation, the forms were initially used in a related study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.

We pooled data for the most comparable outcomes and where data from at least two studies could be included.

Limitations of this study included those inherent in the included studies, self - selection of women for home birth, and insufficient data for some outcomes.

Two trials met the inclusion criteria but only 1 trial involving 11 women provided some outcome data and was included.

We state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.

Twelve of the included studies were judged at low risk of bias for incomplete outcome data on the basis that attrition rate was less than 20 % for all outcomes (other than satisfaction), or missing outcome data were balanced across groups (Begley 2011; Biro 2000; Flint 1989; Harvey 1996; Hicks 2003; Homer 2001; Kenny 1994; McLachlan 2012; North Stafford 2000; Tracy 2013; Turnbull 1996; Waldenstrom 2001).

His research interests include examination of racial disparities in birth outcomes and child health; the adequacy and content of pre-conception, prenatal and inter-conception care; child health services; home visiting, child nutrition; fatherhood; and health data policy.

The MANA Stats data reflects not only the outcomes of mothers and babies who birthed at home, but also includes those who transferred to the hospital during a planned home birth, resolving a common concern about home birth data.

Homebirth is in America as Homebirth in America does, yet the Homebirth advocates who are looking at the actually data are making excuses about the worse outcomes as they speculate that it is either due to the high risks births that were included, or because they must have been farther away from the hospital than just 5 minutes, or just ignoring the outcomes data and focusing on the low intervention data.

To be included in this critical review, studies had to be U.S. - based randomized trials evaluating a breastfeeding promotion intervention, reporting breastfeeding outcome data, enrolling primarily minority participants, and conducting analyses by intention to treat.

Studies had to be case control for the purpose of the statistical analysis; have breastfeeding as a measured exposure and leukemia as a measured outcome; include data on breastfeeding duration in months, including but not limited to, 6 months or more (where relevant data were unavailable in the publication, the authors of the studies were contacted); and been published in peer - reviewed journals with full text available in English.

Study Selection To be included in the meta - analyses, studies had to be case control; include breastfeeding as a measured exposure and leukemia as a measured outcome; include data on breastfeeding duration in months; and be published in a peer - reviewed journal with full text available in English.

To be included in the meta - analyses, studies had to be case control; include breastfeeding as a measured exposure and leukemia as a measured outcome; include data on breastfeeding duration in months; and be published in a peer - reviewed journal with full text available in English.

Two trials met the inclusion criteria but only one trial involving 11 women provided some outcome data and was included.

We had prespecified that we would not include data for any outcome where there were missing data for more than 25 % of the randomised group.

We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.

We have not included outcomes in the analyses where more than 25 % of the data were missing.

Correction, 9 March, 4 p.m.: This article has been updated to include a discussion of the doctoral career outcome data from alumni of Cornell University Graduate School.

The best solutions to date for figuring out their career outcomes include trawling the Internet to track postdocs from labs with funding from National Institutes of Health T32 institutional training grants, which require that all lab personnel be listed, and manually curating a postdoc outcome database using piecemeal data from a variety of sources, both of which are very labor intensive and potentially error prone.

It also included limited data on outcomes and complications, such as facial numbness.

The researchers found that many data sources do not include information on potential risk factors that affect health outcomes, such as use of illicit substances, use of over-the-counter medicines, smoking, and actual adherence to the medication.

The researchers assigned risk categories to each of the operations performed in the data pool, including colorectal and liver resections, and then compared 30 - day postsurgical outcomes among patients within similar risk groups.

Finally, all of this data can be combined to predict patient outcomes including overall survival.

They measured educational outcomes using standardized tests and looked at demographic data, including attendance and suspension; race and ethnicity; free and reduced price lunch status; and participation in gifted education, special education, or programs for English learners.

Dr. Grant and colleagues also performed a separate analysis of data from eight studies — including 838 patients — assessing nausea and vomiting as the main outcome of interest.

A 2013 paper in the same journal reported excellent vocal outcomes for the first 92 treated patients, but neither paper included the kind of follow - up data required to confirm the treatment's long - term effectiveness in curing the tumors.

This data was then compared with patients» outcomes, including heart attack or the occurrence of major adverse cardiac events within 30 days.

Jon Davis and colleagues at the University of Cincinnati in Ohio collected outcome data on 80,000 people in the US who had had weight - loss surgery, including Roux - en - Y.

Researchers examined outcome data between 2011 and 2014 on the eight most common conditions in seniors treated by general internists, including sepsis, pneumonia, congestive heart failure, and acute renal failure.

Limitations of the study include that causality of adverse events can not be determined from the data, health outcomes are self - reported and reports from consumers vs. health care professionals can not be distinguished.

The USIDNET registry gathers variables including clinical, laboratory and outcome data, which together provide a health survey of the relatively small number of patients affected by primary immunodeficiency disorders.

The study included data about human - animal interactions, physical activity, frequency of doctor visits and health outcomes of the participants.

Their analysis included data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, which contained repeated assessments of marijuana use and kidney outcomes.

The current study combines data from five clinical trials involving a total of 1,287 people, including the SWIFT PRIME trial led by Saver, that show these devices improved outcomes for people with acute ischemic strokes due to large vessel blockage.

Using data from a sample of 2,615 active duty military families, living at designated military installations with a child ages 3 - 17, a group of researchers led by Dr. Patricia Lester, of the University of California, Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior, examined the impact of FOCUS on behavioral health outcomes, including depression, anxiety, and child pro-social behavior over two follow up assessments.

Working closely with more than 200 data contributors, WWARN is able to use this powerful resource to perform pooled analyses that uncover new insights into the emergence and spread of malaria drug resistance, including evaluating the efficacy of antimalarial combination therapies (ACTs), and examining whether known molecular markers can predict clinical outcomes.